Seer will establish the Seer Technology Access Center to showcase its latest product, the Proteograph XT Assay Kit, in combination with the Thermo Scientific Orbitrap Astral mass spectrometer (MS).

According to Seer, the combination of these products will enable unprecedented depth and scale in complex biological samples, with more than 6,000 protein identifications and more than 42,000 peptide identifications per sample from human plasma.

Its new center will address an important unmet need for researchers who do not have access to mass spectrometry but wish to undertake deep unbiased proteomics studies; those would include translational and genomics researchers performing population-scale studies with deep molecular profiling, Seer said.

Furthermore, Seer and Thermo Fisher will develop and optimize proteomics and proteogenomics workflows, including the integration of data and analysis protocols.

The Seer Technology Access Center will provide mass spectrometry services on the Thermo Scientific Orbitrap Astral MS to new Proteograph XT customers, as well as end-to-end solutions to customers who are looking for access to the biological insights that can only be gained from deep, unbiased proteomics, Seer said.

Machine learning finds potential brain cancer drug targets in multi-omics dataset
Researchers have applied machine learning to a multi-omics dataset to identify the kinases that drive tumor growth and drug resistance in certain types...

Proteomic signature improves detection of hard-to-identify form of prediabetes
Testing for a three-protein signature in the blood could improve the detection of a form of prediabetes, according to research published November 10 in...

Benchtop single-molecule protein sequencing unlocks new way to study proteome
Life sciences company Quantum-Si has developed a benchtop instrument that performs single-molecule protein sequencing, setting the stage for a new approach...

Seer debuts new proteomic-mapping software
Seer has launched a new Proteogenomics Workflow that integrates deep proteomics with genomics and is powered by the Proteograph Analysis Suite 2.0.

NCI awards $4.2M to Mount Sinai to create Proteogenomic Data Analysis Center
The National Cancer Institute (NCI) has awarded $4.2 million over five years to Mount Sinai researchers to establish a Proteogenomic Data Analysis Center...